Catalase (CAT), a potent antioxidant used to treat neurodegenerative diseases by inhibiting inflammation and protecting dopaminergic neurons, is limited by the impermeability of the blood–brain barrier to most therapeutic agents (42, 43). Here, CAT is linked to neurodegenerative disease.